Tag: Alzheimer’s
Neighborhood Deprivation Tied to Poorer Cognition
Link possibly involves greater burden of small vessel disease and modifiable risk factors
Increased Mortality Seen Among Patients With Early-Onset Dementia
Frontotemporal dementia spectrum patients have highest all-cause mortality among all dementia subtypes
Intranasal Insulin, Empagliflozin Have Promising Effects on Cognition
Intranasal insulin increased mPACC-5, modulated fractional anisotropy and cerebral blood flow
Mortality Increased With Benzodiazepines, Antipsychotic Use in ADRD Patients
Elevated 180-day mortality reported for nursing home residents with Alzheimer disease and related dementias receiving hospice care
FDA Clears New Blood Test to Help Rule Out Alzheimer’s Disease
The Elecsys pTau181 blood test correctly identified people without Alzheimer’s in 97.9% of cases
Age at Start of Estrogen Therapy May Affect Alzheimer Disease Risk
Up to 32 percent lower risk conferred by early initiation, while increased risk for dementia seen in studies among older women
PM2.5 Exposure Linked to Increased Dementia Severity
Higher PM2.5 exposure prior to death linked to increased odds of more severe Alzheimer disease neuropathologic change
Alzheimer Disease Associated With Greater Neural Flexibility
Neural flexibility also predicts dementia transition
Sense of Life Purpose Lowers Risk for Cognitive Impairment
Findings persisted even among people at high genetic risk for dementia
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
Leqembi Iqlik allows for at-home maintenance dosing after initial 18 months of intravenous dosing
